Over the past 20 years our research has contributed to transforming the lives of patients with diseases of the blood, including non-Hodgkin lymphoma. We have a dedicated, ongoing programme of ...

Non-Hodgkin lymphoma is a cancer that affects lymphocytes, a type of white blood cells in the lymphatic system. They are generally classified according to the cancer's growth rate as high grade ...

Among adults with relapsed or refractory indolent B-cell non-Hodgkin lymphoma, the phase 2 TRANSCEND FL trial met its primary ...

However, the five-year survival rate for all stages of non-Hodgkin lymphoma is 65%, with regional lymphomas (like stage 3) at 74%. “In general, the goal of treatment is [a cure],” Bond said.

The rate of non-Hodgkin's lymphoma has nearly doubled since the 1970s, but advances in treatments are offering new hope. Laura Colton Tepper had just endured her second round of chemotherapy for ...

The five-year relative survival rate for stage 4 Hodgkin lymphoma is 81 percent, and 64 percent for stage 4 non-Hodgkin lymphoma. Conor E. Steuer, MD, is medical oncologist specializing in the ...

Navigating the Shifting Terrain of Diffuse Large B-Cell Lymphoma Treatment: Insights for Early-Career Physicians Dr Kami Maddocks advises early-career physicians regarding the evolution of DLBCL ...

Primary non-Hodgkin's lymphoma of the breast (PBNHL) is uncommon. There have been only a few reports of breast lymphoma in the radiology literature. In this case report, we describe mammographic ...

David Livingston/Getty Images Since going public with his Stage 3 non-Hodgkin lymphoma diagnosis in November 2024, Dave Coulier has been candid about his illness, treatment and prognosis. Non-Hodgkin ...

The Committee for Medicinal Products for Human Use (CHMP) has recommended that the CD19-directed CAR T cell therapy, which is already approved in the EU for certain lymphomas, be authorised to treat ...